ArticleCureus2026
Frailty Syndrome in Non-geriatric Dialysis Patients in Georgia: Prevalence and Clinical Correlates in a Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Frailty is a multidimensional syndrome strongly associated with poor quality of life, hospitalization, and mortality in patients with chronic kidney disease (CKD). While frailty in dialysis populations has been well characterized in geriatric patients, its prevalence and correlates among non-geriatric adults remain poorly understood. Methods This cross-sectional study enrolled 50 non-geriatric patients (aged 18-64 years) with CKD stage 5D (dialysis-dependent) receiving maintenance hemodialysis at a single center in Tbilisi, Georgia. Frailty was assessed using the FRAIL (Fatigue, Resistance, Ambulation, Illness, and Loss of weight) scale, classifying participants as robust, prefrail, or frail. Demographic data, body mass index (BMI), smoking status, comorbidities, and biochemical correlates were evaluated using Fisher's exact test and multinomial logistic regression. Results The mean age was 54.34 ± 8.26 years, and 33 (66%) participants were male. Prefrailty was the most common classification, affecting 22 (44%) participants, followed by robust status in 18 (36%) and frailty in 10 (20%). In multinomial regression, smoking history (pack-years) was inversely associated with frailty in both the frail-vs-robust (p = 0.021) and prefrail-vs-frail (p = 0.005) comparisons. Phosphate levels were significantly associated with frailty in the prefrail-vs-frail comparison (p = 0.04) and showed a non-significant trend in the frail-vs-robust comparison (p = 0.092). Dialysis duration was significantly associated with frailty in the prefrail-vs-frail comparison only (p = 0.016). A non-linear relationship between BMI and frailty was observed, with the highest frailty prevalence among participants with class I obesity, affecting four (57.14%) participants of that subgroup. Comorbidities showed no statistically significant associations with frailty status. Conclusion Frailty and prefrailty are common among non-geriatric patients with CKD stage 5D, indicating that frailty in this population is not solely age-driven. Phosphate levels and dialysis duration emerged as clinically relevant correlates, supporting the incorporation of routine frailty screening in non-geriatric dialysis care. Larger longitudinal multi-center studies are needed to confirm these findings and clarify their prognostic significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.